This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 27/5/1166    most recent ATVBAHA.106.138594v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by López-Bermejo, A. Articles by Fernández-Real, J.-M. Search for Related Content PubMed PubMed Citation Articles by López-Bermejo, A. Articles by Fernández-Real, J.-M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL Medline Plus Health Information Vascular Diseases

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:1166.)
© 2007 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Alpha Defensins 1, 2, and 3

Potential Roles in Dyslipidemia and Vascular Dysfunction in Humans

Abel López-Bermejo; Berta Chico-Julià; Antoni Castro; Mònica Recasens; Eduardo Esteve; Josefina Biarnés; Roser Casamitjana; Wifredo Ricart; José-Manuel Fernández-Real

From the Diabetes, Endocrinology, and Nutrition Unit (A.L.-B., B.C.-J., M.R., E.E., J.B., W.R., J.-M.F.-R.) and Internal Medicine (A.C.), Dr Josep Trueta Hospital, Girona; the Girona Institute for Biomedical Research (A.L.-B., B.C.-J., A.C., M.R., E.E., J.B., W.R., J.-M.F.-R.), Girona; and the Endocrine Laboratory (R.C.), University Clinical Hospital, Barcelona, Spain.

Correspondence to Abel López-Bermejo, MD, Unit of Diabetes, Endocrinology, and Nutrition, Dr Josep Trueta Hospital, Av. Francia s/n, 17007 Girona, Spain. E-mail uden.alopez{at}htrueta.scs.es

Objectives— -Defensins are natural antibiotics made by neutrophils that have been reported to modulate cholesterol metabolism and vascular function; however, their role in vivo remains largely unknown. We hypothesized that -defensins 1 to 3 (DEFA1–3) are associated with serum lipids and vascular reactivity in humans.

Methods and Results— One hundred thirteen apparently-healthy White men, participants in a prospective study of cardiovascular risk factors, were assessed for a lipid profile, insulin sensitivity (S_I, frequently-sampled intravenous glucose tolerance test), and non-stressed circulating DEFA1–3 (ELISA). In a subset of 52 subjects, vascular reactivity (high-resolution ultrasound of the brachial artery) was also assessed. Subjects in the highest quartile for plasma DEFA1–3 were found to be leaner and more insulin sensitive, and to have significantly reduced total and LDL-cholesterol, compared with subjects in the lowest quartile for circulating DEFA1–3 (P<0.0001 to P=0.002 for linear trend ANOVA). The associations with serum lipids persisted after adjustment for age, body mass index, insulin sensitivity, and smoking (which was associated with reduced plasma DEFA1–3 concentrations). Finally, endothelium-independent vasodilation increased with increasing circulating DEFA1–3 (P=0.003) and this association was not explained by age, body mass index, serum cholesterol, insulin sensitivity, or smoking.

Conclusions— Circulating DEFA1–3 are associated with serum cholesterol and vascular reactivity in humans. -Defensins may have clinical implications in patients with either hypercholesterolemia or vascular dysfunction.

-Defensins (natural antibiotics made by neutrophils) can modulate cholesterol metabolism and vascular function. In apparently-healthy White men, plasma -defensins 1 to 3 (DEFA1–3) were decreased with increasing body weight and smoking, and reduced circulating DEFA1–3 was associated with higher total and LDL-cholesterol concentrations. Decreased DEFA1–3 was also associated with poorer endothelial-independent vasomotor responses in these subjects. -Defensins may have clinical implications in patients with either hypercholesterolemia or vascular dysfunction.

Key Words: human neutrophil peptide • defensin • cholesterol • insulin resistance • vascular function

This article has been cited by other articles:

				K. Quinn, M. Henriques, T. Parker, A. S. Slutsky, and H. Zhang Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1817 - H1824. [Abstract] [Full Text] [PDF]

				F. Syeda, E. Tullis, A. S. Slutsky, and H. Zhang Human neutrophil peptides upregulate expression of COX-2 and endothelin-1 by inducing oxidative stress Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2769 - H2774. [Abstract] [Full Text] [PDF]

				J. M. Moreno-Navarrete, F. J. Ortega, J. Bassols, A. Castro, W. Ricart, and J. M. Fernandez-Real Association of Circulating Lactoferrin Concentration and 2 Nonsynonymous LTF Gene Polymorphisms with Dyslipidemia in Men Depends on Glucose-Tolerance Status Clin. Chem., February 1, 2008; 54(2): 301 - 309. [Abstract] [Full Text] [PDF]